With the recent resurgence of A-share market, financing funds with high risk preference began to accelerate their entry. According to the data of the stock exchange, as of May 17, the financing balance of Shanghai and Shenzhen stock markets has increased for six consecutive trading days, reaching a new high in nearly two and a half months. Restricted by the high cost of capital, financing funds tend to seek profit opportunities in the short-term strong plate, and the biological vaccine and intelligent car plate which has been rapidly rising recently has naturally become the first choice to buy. As the leading benchmark of these two sectors, Fosun Pharma
ceutical and Chang'an automobile have increased their financing balance by 2.218 billion yuan and 1.235 billion yuan respectively since May, ranking the top two of all the two financial target stocks.